fbpx COVID-19 (Coronavirus): ADB's Response | Asian Development Bank

COVID-19 (Coronavirus): ADB's Response

ADB is supporting its developing members in responding to the COVID-19 pandemic through finance, knowledge, and partnerships.

In the Spotlight

Article | 09 Aug 2021

Surge in COVID-19 Cases Highlights Need to Ramp Up Vaccinations in Asia and the Pacific

A surge in new COVID-19 cases in the middle of 2021 has again highlighted the need to speed and scale up vaccination programs in Asia and the Pacific.

Blog Entry | 27 Aug 2021

We are just now discovering how devastating COVID-19 has been for the very poor

To cope with the pandemic, Asia’s poor are missing meals and selling their assets. Governments need to target policies toward the most vulnerable in order to stave off long-term damaging impacts.

Publication | 19 Aug 2021

Can Vaccination Help Restart Tourism?

This brief explores how introducing vaccine passes could support cross-border travel and help revive the tourism sector.

News Release

$9 Billion ADB Facility to Help Developing Member Countries Access and Distribute COVID-19 Vaccines

ADB has launched a $9 billion vaccine initiative—the Asia Pacific Vaccine Access Facility (APVAX)—offering rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines.

ADB’s COVID-19 response consists of a $20 billion package announced in April 2020 and the $9 billion Asia Pacific Vaccine Access Facility (APVAX) announced in December 2020.

ADB’s initial $20 billion COVID-19 response package supports its developing member countries in countering the severe macroeconomic and health impacts caused by COVID-19, including $2.5 billion in concessional and grant resources, as well as $2 billion earmarked for the private sector (non-sovereign).

ADB's $9 billion APVAX vaccine initiative offers rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines.

Committed Amount is the financing approved by ADB's Board of Directors or Management for which the legal agreement has been signed by the borrower, recipient, or the investee company and ADB.
*Projects may be listed in more than one country or subregion. The number of projects excludes short-term finance transactions under the Trade Finance, Supply Chain Finance, and Microfinance Programs.

News and Multimedia   Subscribe to our newsletter

Publications and Documents


Milestones

Made with Flourish